Foreign body aspiration infant - Nursing Case Study

Pathophysiology

• Primary mechanism: Foreign body aspiration in infants generally occurs when a small object enters the airway, often due to the underdeveloped swallowing and cough reflexes, leading to obstruction of the trachea or bronchi. This can result in partial or complete blockage, compromising airflow and oxygen exchange.

• Secondary mechanism: Inflammatory response is triggered by the presence of the foreign object, causing local swelling and edema, which can exacerbate airway obstruction. This inflammation can lead to irritation and increased mucus production, further narrowing the airway.

• Key complication: If not promptly addressed, foreign body aspiration can lead to respiratory distress, hypoxia, or even asphyxia. Long-standing obstruction can cause atelectasis or recurrent infections, underscoring the need for swift intervention to restore airway patency.

Patient Profile

Demographics:

8-month-old male, infant (no relevant occupation)

History:

• Key past medical history: No significant past medical history

• Current medications: None

• Allergies: No known allergies

Current Presentation:

• Chief complaint: Difficulty breathing and persistent coughing

• Key symptoms: Wheezing, cyanosis around lips, decreased appetite, irritability

• Vital signs: Temperature 38.3°C, Heart rate 160 bpm, Respiratory rate 50 breaths/min, Oxygen saturation 88% on room air

Section 1

As the infant's condition is assessed further, the healthcare team notes a worsening of symptoms. The infant exhibits increased work of breathing, characterized by marked intercostal and subcostal retractions. Auscultation reveals diminished breath sounds on the right side, with persistent wheezing heard throughout the lung fields. These findings are suggestive of a potential partial airway obstruction, likely due to the foreign object that has been aspirated. The cyanosis around the lips has intensified, indicating a further compromise in oxygenation. Despite supplemental oxygen therapy, the infant's oxygen saturation remains concerning at 85%, pointing towards a critical need for immediate intervention to prevent further deterioration.

Given the evolving clinical picture, the medical team decides to perform a rigid bronchoscopy under general anesthesia to locate and remove the foreign object. The procedure reveals a small piece of plastic lodged in the right main bronchus, confirming the cause of the obstruction. Following the successful removal of the object, the infant's respiratory status temporarily improves; however, the inflammatory response persists. Post-procedural assessment shows continued tachypnea with a respiratory rate of 48 breaths/min and an oxygen saturation of 92% on room air, suggesting residual airway edema and inflammation.

In the following hours, the infant begins to exhibit signs of respiratory fatigue. The heart rate remains elevated at 158 bpm, and the infant is increasingly lethargic, with a decreased response to stimuli. These changes suggest the possibility of developing respiratory failure if swift action isn't taken to manage the airway edema and ensure adequate ventilation. This necessitates the initiation of corticosteroid therapy to reduce inflammation and close monitoring in a pediatric intensive care setting. The team prepares for potential escalation of respiratory support should the infant's condition fail to stabilize, emphasizing the importance of ongoing clinical vigilance and timely interventions.

Section 2

As the infant is closely monitored in the pediatric intensive care unit, the healthcare team observes a further change in the patient's status that indicates new complications are arising. Despite the initiation of corticosteroid therapy, the infant's respiratory rate remains elevated, with no significant improvement in oxygen saturation levels, which hover around 90% on supplemental oxygen. The infant exhibits increased lethargy and decreased muscle tone, raising concerns about worsening respiratory fatigue and potential impending respiratory failure. These clinical signs prompt the team to reassess the current management plan, considering the need for more aggressive interventions to ensure adequate oxygenation and ventilation.

Arterial blood gas analysis provides additional insight into the infant's deteriorating condition. The results reveal a pH of 7.32, indicating respiratory acidosis, with a partial pressure of carbon dioxide (PaCO2) elevated at 55 mmHg, and a partial pressure of oxygen (PaO2) at 60 mmHg. These findings confirm the presence of hypoventilation and inadequate gas exchange, likely resulting from the persistent airway edema and inflammation post-foreign body removal. In light of these results, the medical team deliberates the need for non-invasive positive pressure ventilation to support the infant's breathing efforts while continuing with corticosteroids to address airway swelling.

Recognizing the critical need for continuous monitoring and timely interventions, the team also considers the potential for further complications, such as secondary bacterial infection or atelectasis, given the prolonged airway compromise. A chest X-ray is ordered to assess for any signs of lung collapse or consolidation that might contribute to the infant's worsening status. The interdisciplinary team remains vigilant, ready to escalate care as needed, while also exploring adjunct therapies, such as nebulized bronchodilators, to optimize airway patency and support the infant's recovery.

Section 3

As the healthcare team continues to monitor the infant in the pediatric intensive care unit, a new set of diagnostic results sheds light on the evolving clinical picture. The chest X-ray reveals areas of lung consolidation in the right lower lobe, raising the suspicion of atelectasis or a possible aspiration pneumonia secondary to the recent foreign body event. The presence of consolidation, coupled with the infant's persistent hypoxemia and respiratory distress, prompts the team to initiate a targeted antibiotic regimen, anticipating a secondary bacterial infection as a potential complication.

Simultaneously, the decision is made to commence non-invasive positive pressure ventilation (NIPPV) to enhance alveolar ventilation and improve gas exchange. The infant is carefully fitted with a nasal mask connected to the NIPPV device, and settings are adjusted to deliver adequate positive end-expiratory pressure (PEEP) and inspiratory support. Within hours of initiating this intervention, there is a slight improvement in oxygen saturation, increasing to 92% on the same level of supplemental oxygen. However, the infant remains tachypneic with a respiratory rate of 55 breaths per minute, and arterial blood gas analysis continues to show mild respiratory acidosis with a pH of 7.34 and a PaCO2 of 50 mmHg.

While the initial response to interventions suggests a stabilization of the infant's condition, the clinical team remains cautious and vigilant for any signs of further deterioration. The possibility of additional complications, such as worsening atelectasis or the development of acute respiratory distress syndrome (ARDS), necessitates ongoing reassessment and adjustment of the treatment plan. The interdisciplinary team discusses the potential benefits of adjunct therapies, including nebulized bronchodilators, to further reduce airway resistance and assist with the clearance of secretions. The next steps in the infant's care will depend on continued observation and the response to current therapeutic measures, with the overarching goal of preventing progression to respiratory failure and ensuring a safe recovery trajectory.

Section 4

As the multidisciplinary team closely monitors the infant's progress, a new set of diagnostic results provides further insight into the evolving situation. A repeat chest X-ray taken 12 hours after the initiation of non-invasive positive pressure ventilation (NIPPV) shows a slight reduction in the extent of right lower lobe consolidation, suggesting a partial response to the antibiotic regimen. However, there is now evidence of new patchy infiltrates in the right middle lobe, raising concerns about the potential spread of infection or the development of a secondary bacterial bronchopneumonia. The infant's blood cultures, drawn prior to starting antibiotics, return positive for Streptococcus pneumoniae, confirming the presence of a bacterial pathogen and validating the choice of an antibiotic regimen that includes coverage for this organism.

Clinically, the infant's respiratory status remains tenuous. While oxygen saturation levels have improved to 94% with the assistance of NIPPV, the infant continues to exhibit signs of respiratory distress, with persistent tachypnea and increased work of breathing. The heart rate is slightly elevated at 160 beats per minute, and the latest arterial blood gas analysis reveals a pH of 7.33 with a PaCO2 of 52 mmHg, indicating a slight worsening of respiratory acidosis. These findings suggest an ongoing struggle to maintain adequate ventilation and gas exchange, despite the current interventions.

In response to these developments, the healthcare team discusses the potential need for escalation of respiratory support. Given the risk of progression to acute respiratory distress syndrome (ARDS) and the presence of worsening acidosis, the team considers the possibility of transitioning to invasive mechanical ventilation if there is no significant improvement within the next 6-12 hours. Concurrently, they explore the option of adding nebulized bronchodilators to the treatment plan, aiming to enhance airway patency and secretion clearance. Recognizing the delicate balance between intervention and the infant's fragile condition, the team emphasizes the importance of continual reassessment and dynamic adjustment of the treatment strategy, with the goal of preventing further complications and promoting recovery.

Section 5

As the hours progress, the infant's condition takes a concerning turn, prompting the healthcare team to focus on a change in patient status. Despite the ongoing use of non-invasive positive pressure ventilation, the infant begins to exhibit increased signs of respiratory distress. The respiratory rate escalates to 72 breaths per minute, and there is noticeable nasal flaring and intercostal retractions, indicative of significant respiratory effort. Oxygen saturation, which had been maintained at 94%, now intermittently drops to 88%, even with increased FiO2. These changes prompt an urgent reassessment of the current management plan.

In light of the infant's deteriorating respiratory status, a repeat arterial blood gas analysis is performed, revealing a pH of 7.28 and a further elevated PaCO2 of 58 mmHg, confirming worsening respiratory acidosis. This escalation in acidosis signals a critical need for more aggressive intervention to support ventilation and prevent further decline. The multidisciplinary team urgently convenes to review the potential for transitioning to invasive mechanical ventilation, weighing the risks and benefits given the infant's fragile state. Simultaneously, the possibility of adding nebulized bronchodilators is revisited, with the goal of optimizing airway clearance and reducing airway resistance.

As the team deliberates on the next steps, they emphasize the importance of maintaining a comprehensive approach to care. The potential development of acute respiratory distress syndrome (ARDS) looms, necessitating vigilant monitoring for signs of systemic inflammation and worsening pulmonary function. The team remains poised to adapt the treatment strategy dynamically, continually integrating new clinical findings and diagnostic results to guide care. The immediate focus is on stabilizing the infant's respiratory status while preparing for potential complications, ensuring all resources are aligned to support the infant's recovery trajectory.